Skip to main content
Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, Canada - Size and Forecast 2024-2028

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, Canada - Size and Forecast 2024-2028

Published: Jul 2024 172 Pages SKU: IRTNTR70298

Market Overview at a Glance

$880.6 Mn
Market Opportunity
13.64%
CAGR
11.73
YoY growth 2023-2024(%)

Methicillin-Resistant Staphylococcus Aureus Testing Market Size 2024-2028

The methicillin-resistant staphylococcus aureus (MRSA) testing market size is forecast to increase by USD 880.6 million at a CAGR of 13.64% between 2023 and 2028.

  • The market is experiencing significant growth due to several key drivers. The increasing incidence of staphylococcal infections, particularly MRSA, is a major factor fueling market growth. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly being integrated into MRSA testing systems to enhance automation and improve diagnostic accuracy. According to the Centers for Disease Control and Prevention (CDC), approximately 80,000 invasive MRSA infections occur in the United States each year. Moreover, the demand for infection control committees in hospitals is on the rise as healthcare facilities strive to prevent the spread of MRSA and other healthcare-associated infections.
  • Additionally, advancements in molecular diagnostic technologies, such as PCR (polymerase chain reaction) and nucleic acid amplification tests, are enabling faster and more accurate MRSA diagnosis, further boosting market growth.  Risk factors related to HA-MRSA (healthcare-associated MRSA) and CA-MRSA (community-associated MRSA) infections, such as prolonged hospital stays, invasive medical procedures, and crowded living conditions, further contribute to the market growth.

What will be the Size of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market During the Forecast Period?

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Size

 Request Free Sample

  • The market is a significant sector in the life sciences industry, focusing on detecting and identifying MRSA infections. Various testing methods are employed, including culture-based techniques and molecular techniques such as PCR (Polymerase Chain Reaction) and nucleic acid amplification tests (NAATs). Key components of MRSA testing include inspection equipment, such as microbiology media and automation systems, and equipment for designing, manufacturing, and supply chain services. Passive components, like culture plates and swabs, and active components, like automated systems and robotics, are crucial for efficient and accurate testing.
  • The healthcare sector is a major end-user, with consumer electronics, IT & telecommunication, industrial, aerospace & defense, and other industries also utilizing MRSA testing. The antibiotic resistant strain of MRSA presents a significant public health threat, prompting the development of novel MRSA diagnostic tests that leverage automation and systems to improve accuracy. Surgical infections and chronic diseases, including skin diseases, require effective treatment strategies, such as next-generation antibiotics like vancomycin and daptomycin, which are central to MRSA therapy. Glycopeptides remain a key class of drugs for treating skin and soft tissue infections, while beta lactam antibiotics like Zevtera, and other drug classes like lipopeptide, oxazolidinone, cephalosporin, tetracycline, and lipoglycopeptide, continue to play vital roles in combatting bacterial infections. Folate antagonists are also being explored for their potential in fighting resistant strains.

How is this Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • End-user
    • Hospitals and diagnostic laboratories
    • Academic and research institutes
  • Type
    • Molecular diagnostics
    • Immunodiagnostics
  • Geography
    • North America
      • Canada
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • Japan
    • Rest of World (ROW)

By End-user Insights

  • The hospitals and diagnostic laboratories segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth due to the increasing demand for advanced Electronic Devices (EDs), PCBs (Printed Circuit Boards), and components such as Active Components and Passive Components. Automation, Robotics, Artificial Intelligence (AI), and Machine Learning (ML) are key trends driving the market, with inspection equipment, soldering equipment, screen printing equipment, placement equipment, and cleaning equipment being essential tools for SMT manufacturing. Designing services, supply chain services, manufacturing services, and aftermarket services are also integral parts of the SMT ecosystem. Key industries driving the MRSA testing market include Consumer Electronics, IT & Telecommunication, Industrial, Aerospace & Defense, and Healthcare.

New product launches in these sectors, such as Micron Technology's latest DRAM products, Defense spending, and the rise of new technologies like Silicon Carbide (SiC) in Electric Vehicles (EVs) and Solar panels, are expected to fuel market growth. IPC standards and regulations also play a crucial role in ensuring quality and safety in SMT manufacturing.

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Size

Get a glance at the  Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry report of share of various segments Request Free Sample

The hospitals and diagnostic laboratories segment was valued at USD 412.00 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

  • North America is estimated to contribute 42% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Share by Geography

For more insights on the market share of various regions, Request Free Sample

The market is experiencing significant growth due to the increasing demand for Electronic Devices (EDs), Printed Circuit Boards (PCBs), and advanced components such as active components and passive components. Automation, robotics, artificial intelligence (AI), and machine learning (ML) are revolutionizing the manufacturing process, leading to the adoption of advanced inspection equipment.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry?

The increasing incidence of staphylococcal infections is the key driver of the market.

  • The rise of antibiotic-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA), has led to a significant increase in staphylococcal infections, predominantly in healthcare settings such as hospitals, dialysis centers, and nursing homes. Prolonged hospital stays and exposure to open body surfaces due to invasive medical procedures contribute to this trend. For instance, the NHS in the UK reported 846 cases of hospital-acquired MRSA bloodstream infections between April 2017 and March 2018. The Centers for Disease Control and Prevention (CDC) estimates that approximately one in three (33%) people carry Staphylococcus aureus, with a significant portion being resistant to antibiotics.
  • This issue extends beyond healthcare, as the electronics industry, including sectors like consumer electronics, IT & telecommunication, industrial, aerospace & defense, and healthcare, relies heavily on surface mount technology (SMT) for manufacturing electronic devices, PCBs, and various components such as active and passive components. The integration of automation, artificial intelligence (AI), and machine learning (ML) in manufacturing processes, including inspection equipment, soldering equipment, screen printing equipment, placement equipment, and cleaning equipment, has streamlined production and improved quality. However, the presence of MRSA and other bacteria in manufacturing environments poses a significant threat to product quality and worker health. As manufacturing environments become more automated and advanced, maintaining cleanliness and reducing bacterial contamination remains a crucial aspect of ensuring the reliability and safety of the products being produced across these sectors.  New product launches in the semiconductor industry, such as Micron Technology's SiC-based products for Electric Vehicles (EVs) and Solar panels, require stringent manufacturing processes to ensure product integrity and consumer safety.

What are the market trends shaping the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry?

Increasing demand for infection control committees in hospitals is the upcoming market trend.

  • MRSA, or Methicillin-resistant Staphylococcus aureus, is a significant concern in healthcare settings, with an estimated 1 in 25 hospital patients contracting a healthcare-associated infection. To combat this issue, hospitals have established infection control committees, which prioritize measures to prevent MRSA. These committees focus on evidence-based practices, resource allocation, and infection control planning. In the realm of electronics manufacturing, similar attention to detail is essential to ensure the production of high-quality products. Surface Mount Technology (SMT) is a common method used in the assembly of electronic devices and printed circuit boards (PCBs). This process involves the placement of active components and passive components using automation and advanced equipment such as inspection equipment, soldering equipment, screen printing equipment, and placement equipment.
  • Cleaning Equipment is also crucial to maintaining a hygienic manufacturing environment. The electronics industry comprises various sectors. New product launches in these sectors drive the demand for advanced manufacturing services. Aftermarket Services are also essential for maintaining the functionality and longevity of these products.

What challenges does the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry face during its growth?

Risk factors related to HA-MRSA and CA-MRSA infections is a key challenge affecting the industry growth.

  • MRSA (Methicillin-resistant Staphylococcus aureus) infections pose significant challenges in various industries, particularly in healthcare, where vulnerable patient populations, such as pediatrics and geriatrics, are at risk. The spread of MRSA can occur through invasive medical devices like intravenous lines or catheters, prolonged hospital stays, or contact sports and activities. In healthcare settings, MRSA can lead to hospitalization and complications, making effective prevention and detection crucial. Outside of healthcare, MRSA can impact various sectors, including consumer electronics, IT & telecommunication, industrial, aerospace & defense, and healthcare. For instance, in the electronic devices industry, surface mount technology (SMT) and PCBs (printed circuit boards) are susceptible to MRSA contamination during manufacturing.
  • Active and passive components, inspection equipment, soldering equipment, screen printing equipment, and placement equipment are all potential carriers of MRSA. To mitigate these risks, advanced technologies like automation, robotics, artificial intelligence (AI), and machine learning (ML) are increasingly being employed in manufacturing services, designing services, supply chain services, and aftermarket services. New product launches in sectors like consumer electronics, IT & telecommunications, and industrial are incorporating these technologies to improve production efficiency, product quality, and infection control. Defense spending on military and aerospace applications is driving the demand for MRSA testing and prevention in silicon carbide (SiC) components, electric vehicles (EVs), and solar panels.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • 3M Co.
  • Abbott Laboratories
  • ALIFAX Srl
  • Arlington Scientific Inc.
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Bio Rad Laboratories Inc.
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corp.
  • DiaSorin Spa
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • GENSPEED Biotech GmbH
  • OpGen Inc.
  • Puritan Medical Products Co.
  • R Biopharm AG
  • Sekisui Diagnostics LLC
  • Uniogen Oy
  • ZeptoMetrix LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

MRSA testing is a crucial process in the electronics industry to ensure the quality and reliability of surface mount technology (SMT) applications in various sectors. The market for MRSA testing is witnessing significant growth due to the increasing demand for electronic devices (EDs), printed circuit boards (PCBs), and components such as active and passive components. The integration of automation, robotics, artificial intelligence (AI), and machine learning (ML) in manufacturing processes has led to an increased focus on MRSA testing for improved efficiency and accuracy. Inspection equipment and soldering equipment are essential tools for MRSA testing, ensuring the proper placement and connection of components on PCBs.

Cleaning equipment is also vital to maintain the cleanliness of the manufacturing environment and prevent contamination. Designing services, supply chain services, manufacturing services, and aftermarket services are other key areas where MRSA testing plays a significant role. Hospital pharmacy, retail pharmacy, and online pharmacy are key components of the pharmaceutical and healthcare industry, providing essential antiseptics and therapeutic solutions to patients. Clinical assessment and laboratory tests, including cultures, play a crucial role in diagnosing infections and determining the most effective medical therapies. With the rise of antibiotic resistance, alternative antibiotics like linezolid are becoming critical in treating resistant strains. Epidemiology helps identify the patient pool and track the spread of infections, guiding the development of late-stage pipeline drugs and clinical trials. Understanding the pharmacological action of these treatments ensures their efficacy and safety in addressing complex infections.

Market Scope

Report Coverage

Details

Page number

172

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 13.64%

Market Growth 2024-2028

USD 880.6 million

Market structure

Fragmented

YoY growth 2023-2024(%)

11.73

Key countries

US, Germany, UK, Japan, and Canada

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the industry during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
  • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the market growth of industry companies

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market 2018 - 2022
      • Historic Market Size - Data Table on Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market 2018 - 2022 ($ million)
    • 4.2 End-user segment analysis 2018 - 2022
      • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
    • 4.3 Type segment analysis 2018 - 2022
      • Historic Market Size - Type Segment 2018 - 2022 ($ million)
    • 4.4 Geography segment analysis 2018 - 2022
      • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country segment analysis 2018 - 2022
      • Historic Market Size - Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Bargaining power of buyers - Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Threat of new entrants - Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Threat of substitutes - Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Threat of rivalry - Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Chart on End-user - Market share 2023-2028 (%)
      • Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Chart on Comparison by End-user
      • Data Table on Comparison by End-user
    • 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2023-2028
      • Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
      • Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
      • Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
      • Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
    • 6.4 Academic and research institutes - Market size and forecast 2023-2028
      • Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
      • Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
      • Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
      • Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by End-user
      • Market opportunity by End-user ($ million)
      • Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Chart on Type - Market share 2023-2028 (%)
      • Data Table on Type - Market share 2023-2028 (%)
    • 7.2 Comparison by Type
      • Chart on Comparison by Type
      • Data Table on Comparison by Type
    • 7.3 Molecular diagnostics - Market size and forecast 2023-2028
      • Chart on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
      • Data Table on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
      • Chart on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
      • Data Table on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
    • 7.4 Immunodiagnostics - Market size and forecast 2023-2028
      • Chart on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
      • Data Table on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
      • Chart on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
      • Data Table on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Type
      • Market opportunity by Type ($ million)
      • Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Chart on Market share by geography 2023-2028 (%)
      • Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Chart on Geographic comparison
      • Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Chart on North America - Year-over-year growth 2023-2028 (%)
      • Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Chart on US - Market size and forecast 2023-2028 ($ million)
      • Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Chart on US - Year-over-year growth 2023-2028 (%)
      • Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Chart on UK - Year-over-year growth 2023-2028 (%)
      • Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 Japan - Market size and forecast 2023-2028
      • Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Market opportunity by geography ($ million)
      • Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Opportunity/Restraints

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market opportunities/restraints

          11 Competitive Landscape

          • 11.1 Overview
            • 11.2 Competitive Landscape
              • Overview on criticality of inputs and factors of differentiation
            • 11.3 Landscape disruption
              • Overview on factors of disruption
            • 11.4 Industry risks
              • Impact of key risks on business

            12 Competitive Analysis

            • 12.1 Companies profiled
              • Companies covered
            • 12.2 Market positioning of companies
              • Matrix on companies position and classification
            • 3M Co.
              • 3M Co. - Overview
              • 3M Co. - Business segments
              • 3M Co. - Key news
              • 3M Co. - Key offerings
              • 3M Co. - Segment focus
            • 12.4 Abbott Laboratories
              • Abbott Laboratories - Overview
              • Abbott Laboratories - Business segments
              • Abbott Laboratories - Key news
              • Abbott Laboratories - Key offerings
              • Abbott Laboratories - Segment focus
            • 12.5 Arlington Scientific Inc.
              • Arlington Scientific Inc. - Overview
              • Arlington Scientific Inc. - Product / Service
              • Arlington Scientific Inc. - Key offerings
            • 12.6 Becton Dickinson and Co.
              • Becton Dickinson and Co. - Overview
              • Becton Dickinson and Co. - Business segments
              • Becton Dickinson and Co. - Key news
              • Becton Dickinson and Co. - Key offerings
              • Becton Dickinson and Co. - Segment focus
            • 12.7 bioMerieux SA
              • bioMerieux SA - Overview
              • bioMerieux SA - Product / Service
              • bioMerieux SA - Key news
              • bioMerieux SA - Key offerings
            • 12.8 Bio Rad Laboratories Inc.
              • Bio Rad Laboratories Inc. - Overview
              • Bio Rad Laboratories Inc. - Business segments
              • Bio Rad Laboratories Inc. - Key news
              • Bio Rad Laboratories Inc. - Key offerings
              • Bio Rad Laboratories Inc. - Segment focus
            • 12.9 Bruker Corp.
              • Bruker Corp. - Overview
              • Bruker Corp. - Business segments
              • Bruker Corp. - Key news
              • Bruker Corp. - Key offerings
              • Bruker Corp. - Segment focus
            • 12.10 Danaher Corp.
              • Danaher Corp. - Overview
              • Danaher Corp. - Business segments
              • Danaher Corp. - Key news
              • Danaher Corp. - Key offerings
              • Danaher Corp. - Segment focus
            • 12.11 DiaSorin Spa
              • DiaSorin Spa - Overview
              • DiaSorin Spa - Business segments
              • DiaSorin Spa - Key offerings
              • DiaSorin Spa - Segment focus
            • 12.12 Eurofins Scientific SE
              • Eurofins Scientific SE - Overview
              • Eurofins Scientific SE - Business segments
              • Eurofins Scientific SE - Key news
              • Eurofins Scientific SE - Key offerings
              • Eurofins Scientific SE - Segment focus
            • 12.13 F. Hoffmann La Roche Ltd.
              • F. Hoffmann La Roche Ltd. - Overview
              • F. Hoffmann La Roche Ltd. - Business segments
              • F. Hoffmann La Roche Ltd. - Key news
              • F. Hoffmann La Roche Ltd. - Key offerings
              • F. Hoffmann La Roche Ltd. - Segment focus
            • 12.14 GENSPEED Biotech GmbH
              • GENSPEED Biotech GmbH - Overview
              • GENSPEED Biotech GmbH - Product / Service
              • GENSPEED Biotech GmbH - Key offerings
            • 12.15 OpGen Inc.
              • OpGen Inc. - Overview
              • OpGen Inc. - Product / Service
              • OpGen Inc. - Key offerings
            • 12.16 Puritan Medical Products Co.
              • Puritan Medical Products Co. - Overview
              • Puritan Medical Products Co. - Product / Service
              • Puritan Medical Products Co. - Key offerings
            • 12.17 Uniogen Oy
              • Uniogen Oy - Overview
              • Uniogen Oy - Product / Service
              • Uniogen Oy - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Inclusions checklist
                • Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Currency conversion rates for US$
              • 13.4 Research methodology
                • Research methodology
              • 13.5 Data procurement
                • Information sources
              • 13.6 Data validation
                • Data validation
              • 13.7 Validation techniques employed for market sizing
                • Validation techniques employed for market sizing
              • 13.8 Data synthesis
                • Data synthesis
              • 13.9 360 degree market analysis
                • 360 degree market analysis
              • 13.10 List of abbreviations
                • List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market growth will increase by $ 880.6 mn during 2024-2028.

              The Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market is expected to grow at a CAGR of 13.64% during 2024-2028.

              Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market is segmented by End-user( Hospitals and diagnostic laboratories, Academic and research institutes, Academic, research institutes) Type( Molecular diagnostics, Immunodiagnostics, Asia, ROW)

              3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, ZeptoMetrix LLC are a few of the key vendors in the Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market.

              North America will register the highest growth rate of 42% among the other regions. Therefore, the Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Germany, UK, Japan, Canada

              • Increasing incidence of staphylococcal infectionsThe emergence of antibiotic-resistant staphylococcal strains is the driving factor this market.
              • such as MRSA and VRSA is the driving factor this market.
              • has led to an increased incidence of staphylococcal infections. Most staphylococcal infections are known to develop in hospitals and other healthcare settings is the driving factor this market.
              • such as dialysis centers and nursing homes. Prolonged hospitalization and increased exposure to open body surfaces due to the use of invasive clinical procedures have led to a rise in staphylococcal infections in healthcare settings. According to the NHS in the UK is the driving factor this market.
              • 846 cases of hospital-associated MRSA bloodstream infections were reported from April 2017-March 2018. Similarly is the driving factor this market.
              • according to the CDC is the driving factor this market.
              • about one in three (33%) people carry S. aureus bacteria in their nose is the driving factor this market.
              • usually without any illness. About two in every 100 people carry MRSA. Although many people carry MRSA bacteria in their noses is the driving factor this market.
              • most do not develop serious MRSA infections. At the community level is the driving factor this market.
              • the infection mostly occurs in immuno-compromised individuals or by sharing contaminated personal belongings such as needles is the driving factor this market.
              • towels is the driving factor this market.
              • or razors. As per the CDC is the driving factor this market.
              • people addicted to drugs is the driving factor this market.
              • such as opioids is the driving factor this market.
              • are 16 times more likely to develop a staphylococcal infection. This is because these people often share needles or syringes to inject drugs is the driving factor this market.
              • and therefore is the driving factor this market.
              • the bacteria get a fair chance to enter the bloodstream.  Skin and soft tissue infections are the most common type of infections caused by Staphylococcus. The increasing incidence of antimicrobial drug failure in outpatient treatment has led to a rise in the number of skin and soft tissue infections. Thus is the driving factor this market.
              • the rising incidence of staphylococcal infections is a major driver contributing to global MRSA testing market growth during the forecast period. is the driving factor this market.

              The Methicillin-Resistant Staphylococcus Aureus (Mrsa) Testing market vendors should focus on grabbing business opportunities from the Hospitals and diagnostic laboratories segment as it accounted for the largest market share in the base year.